OT ULTRA2 METER
Report
- Report Number
- 2939301-2012-12515
- Event Type
- Injury
- Date Received
- October 31, 2012
- Date of Event
- October 14, 2012
- Report Date
- October 15, 2012
- Manufacturer
- LIFESCAN INC.
- Product Code
- NBW
- PMA / PMN Number
- K053529
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- LA, US
- Reporter Occupation
- PATIENT
Narratives
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.
ON (B)(6) 2012, THE LAY USER/ PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HER ONETOUCH ULTRA2 METER WAS REVERTING TO THE SET UP MODE WHEN SHE WAS TRYING TO TEST. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. ON (B)(6) 2012 AT 3PM, THE ALLEGED ISSUE FIRST STARTED. THE PATIENT REPORTED USING A COMBINATION OF MEDICATIONS INCLUDING NOVOLOG INSULIN ON A SLIDING SCALE AND LANTUS INSULIN 60 UNITS AT NIGHT. THE PATIENT REPORTED MAKING NO CHANGES TO HER USUAL DIET, ACTIVITY LEVEL OR MEDICATIONS DUE TO THE ALLEGED ISSUE. THE PATIENT REPORTED 1 HOUR LATER, SHE FELT "SWEATY." ON (B)(6) 2012 AT 4PM, THE PATIENT REPORTED HAVING SOMETHING TO EAT OR DRINK AS TREATMENT. THE PATIENT DENIED TESTING ON ANOTHER DEVICE. AT THE TIME OF TROUBLESHOOTING, THE CCA CONFIRMED THERE WAS NO MISUSE OF THE PRODUCT, AND THIS WAS NOT THE FIRST TIME THE METER HAS BEEN USED. THE PATIENT REPORTED THAT THE ALLEGED ISSUE DID OCCUR AFTER REPLACING THE BATTERY. REPLACEMENT PRODUCTS WERE SENT. THIS COMPLAINT IS BEING REPORTED AS AN ADVERSE EVENT SINCE THE PATIENT CLAIMS DUE TO THE ALLEGED ISSUE SHE DEVELOPED SYMPTOMS SUGGESTIVE OF HYPOGLYCEMIA AND REQUIRED SELF TREATMENT TO PREVENT FURTHER INJURY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | OT ULTRA2 METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN INC. | 3295806 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 60 YR | Life Threatening| R |